A citation-based method for searching scientific literature

Juliane Gust, Kevin A Hay, Laïla-Aïcha Hanafi, Daniel Li, David Myerson, Luis F Gonzalez-Cuyar, Cecilia Yeung, W Conrad Liles, Mark Wurfel, Jose A Lopez, Junmei Chen, Dominic Chung, Susanna Harju-Baker, Tahsin Özpolat, Kathleen R Fink, Stanley R Riddell, David G Maloney, Cameron J Turtle. Cancer Discov 2017
Times Cited: 616







List of co-cited articles
875 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma.
Christine E Brown, Behnam Badie, Michael E Barish, Lihong Weng, Julie R Ostberg, Wen-Chung Chang, Araceli Naranjo, Renate Starr, Jamie Wagner, Christine Wright,[...]. Clin Cancer Res 2015
351
5

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Michael Weller, Nicholas Butowski, David D Tran, Lawrence D Recht, Michael Lim, Hal Hirte, Lynn Ashby, Laszlo Mechtler, Samuel A Goldlust, Fabio Iwamoto,[...]. Lancet Oncol 2017
478
5

IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor.
Keishi Adachi, Yosuke Kano, Tomohiko Nagai, Namiko Okuyama, Yukimi Sakoda, Koji Tamada. Nat Biotechnol 2018
268
5

Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy.
Kathryn M Cappell, Richard M Sherry, James C Yang, Stephanie L Goff, Danielle A Vanasse, Lori McIntyre, Steven A Rosenberg, James N Kochenderfer. J Clin Oncol 2020
49
10



The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma.
Jianshu Wei, Yang Liu, Chunmeng Wang, Yajing Zhang, Chuan Tong, Guanghai Dai, Wei Wang, John E J Rasko, J Joseph Melenhorst, Wenbin Qian,[...]. Signal Transduct Target Ther 2020
42
11

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition.
Leonid Cherkassky, Aurore Morello, Jonathan Villena-Vargas, Yang Feng, Dimiter S Dimitrov, David R Jones, Michel Sadelain, Prasad S Adusumilli. J Clin Invest 2016
501
5


Taming the beast: CRS and ICANS after CAR T-cell therapy for ALL.
Vipul S Sheth, Jordan Gauthier. Bone Marrow Transplant 2021
37
13

4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.
Adrienne H Long, Waleed M Haso, Jack F Shern, Kelsey M Wanhainen, Meera Murgai, Maria Ingaramo, Jillian P Smith, Alec J Walker, M Eric Kohler, Vikas R Venkateshwara,[...]. Nat Med 2015
809
5

Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy.
Emma C Morris, Sattva S Neelapu, Theodoros Giavridis, Michel Sadelain. Nat Rev Immunol 2022
39
12

EEG findings in CAR T-cell therapy-related encephalopathy.
Aline Herlopian, Jorg Dietrich, Jeremy S Abramson, Andrew J Cole, Michael B Westover. Neurology 2018
24
16

Into the eye of the cytokine storm.
Jennifer R Tisoncik, Marcus J Korth, Cameron P Simmons, Jeremy Farrar, Thomas R Martin, Michael G Katze. Microbiol Mol Biol Rev 2012
4

Effective treatment of severe COVID-19 patients with tocilizumab.
Xiaoling Xu, Mingfeng Han, Tiantian Li, Wei Sun, Dongsheng Wang, Binqing Fu, Yonggang Zhou, Xiaohu Zheng, Yun Yang, Xiuyong Li,[...]. Proc Natl Acad Sci U S A 2020
4

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
Dawei Wang, Bo Hu, Chang Hu, Fangfang Zhu, Xing Liu, Jing Zhang, Binbin Wang, Hui Xiang, Zhenshun Cheng, Yong Xiong,[...]. JAMA 2020
4

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.
Giulio Cavalli, Giacomo De Luca, Corrado Campochiaro, Emanuel Della-Torre, Marco Ripa, Diana Canetti, Chiara Oltolini, Barbara Castiglioni, Chiara Tassan Din, Nicola Boffini,[...]. Lancet Rheumatol 2020
578
4

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.
Ganesh Suntharalingam, Meghan R Perry, Stephen Ward, Stephen J Brett, Andrew Castello-Cortes, Michael D Brunner, Nicki Panoskaltsis. N Engl J Med 2006
4

Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial.
Stephen J Schuster, Richard T Maziarz, Elisha S Rusch, Junlong Li, James E Signorovitch, Vadim V Romanov, Frederick L Locke, David G Maloney. Blood Adv 2020
31
12

NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.
Aaron P Rapoport, Edward A Stadtmauer, Gwendolyn K Binder-Scholl, Olga Goloubeva, Dan T Vogl, Simon F Lacey, Ashraf Z Badros, Alfred Garfall, Brendan Weiss, Jeffrey Finklestein,[...]. Nat Med 2015
510
4

Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits.
Kole T Roybal, Levi J Rupp, Leonardo Morsut, Whitney J Walker, Krista A McNally, Jason S Park, Wendell A Lim. Cell 2016
476
4

A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response.
Paul F Robbins, Sadik H Kassim, Thai L N Tran, Jessica S Crystal, Richard A Morgan, Steven A Feldman, James C Yang, Mark E Dudley, John R Wunderlich, Richard M Sherry,[...]. Clin Cancer Res 2015
455
4

CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells.
Levi J Rupp, Kathrin Schumann, Kole T Roybal, Rachel E Gate, Chun J Ye, Wendell A Lim, Alexander Marson. Sci Rep 2017
354
4

CRISPR-engineered T cells in patients with refractory cancer.
Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis, Adam D Cohen, Kristy L Weber, Eric Lancaster, Patricia A Mangan, Irina Kulikovskaya, Minnal Gupta, Fang Chen,[...]. Science 2020
450
4

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.
Qiurong Ruan, Kun Yang, Wenxia Wang, Lingyu Jiang, Jianxin Song. Intensive Care Med 2020
4

Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity?
Sjoukje J C van der Stegen, David M Davies, Scott Wilkie, Julie Foster, Jane K Sosabowski, Jerome Burnet, Lynsey M Whilding, Roseanna M Petrovic, Sadaf Ghaem-Maghami, Stephen Mather,[...]. J Immunol 2013
85
4

Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis.
Ahmed Abbasi, Stephen Peeke, Nishi Shah, Jennat Mustafa, Fariha Khatun, Amanda Lombardo, Michelly Abreu, Richard Elkind, Karen Fehn, Alyssa de Castro,[...]. J Hematol Oncol 2020
84
4

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma.
Frederick L Locke, Sattva S Neelapu, Nancy L Bartlett, Tanya Siddiqi, Julio C Chavez, Chitra M Hosing, Armin Ghobadi, Lihua E Budde, Adrian Bot, John M Rossi,[...]. Mol Ther 2017
345
4


Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells.
Brian J Cameron, Andrew B Gerry, Joseph Dukes, Jane V Harper, Vivekanandan Kannan, Frayne C Bianchi, Francis Grand, Joanna E Brewer, Minnal Gupta, Gabriela Plesa,[...]. Sci Transl Med 2013
412
4

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT).
Ankit J Kansagra, Noelle V Frey, Merav Bar, Theodore W Laetsch, Paul A Carpenter, Bipin N Savani, Helen E Heslop, Catherine M Bollard, Krishna V Komanduri, Dennis A Gastineau,[...]. Bone Marrow Transplant 2019
56
7

A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy.
Brian Philip, Evangelia Kokalaki, Leila Mekkaoui, Simon Thomas, Karin Straathof, Barry Flutter, Virna Marin, Teresa Marafioti, Ronjon Chakraverty, David Linch,[...]. Blood 2014
187
4

T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.
Marcela V Maus, Andrew R Haas, Gregory L Beatty, Steven M Albelda, Bruce L Levine, Xiaojun Liu, Yangbing Zhao, Michael Kalos, Carl H June. Cancer Immunol Res 2013
337
4

Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia.
Paulina J Paszkiewicz, Simon P Fräßle, Shivani Srivastava, Daniel Sommermeyer, Michael Hudecek, Ingo Drexler, Michel Sadelain, Lingfeng Liu, Michael C Jensen, Stanley R Riddell,[...]. J Clin Invest 2016
161
4

Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.
Jennifer N Brudno, Norris Lam, Danielle Vanasse, Yueh-Wei Shen, Jeremy J Rose, John Rossi, Allen Xue, Adrian Bot, Nathalie Scholler, Lekha Mikkilineni,[...]. Nat Med 2020
93
4


Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function.
Alexander I Salter, Richard G Ivey, Jacob J Kennedy, Valentin Voillet, Anusha Rajan, Eva J Alderman, Uliana J Voytovich, Chenwei Lin, Daniel Sommermeyer, Lingfeng Liu,[...]. Sci Signal 2018
186
4

Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations.
Robert Weinkove, Philip George, Nathaniel Dasyam, Alexander D McLellan. Clin Transl Immunology 2019
118
4

Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myeloma.
Jie Xu, Li-Juan Chen, Shuang-Shuang Yang, Yan Sun, Wen Wu, Yuan-Fang Liu, Ji Xu, Yan Zhuang, Wu Zhang, Xiang-Qin Weng,[...]. Proc Natl Acad Sci U S A 2019
166
4

Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience.
Cor H J Lamers, Stefan Sleijfer, Arnold G Vulto, Wim H J Kruit, Mike Kliffen, Reno Debets, Jan W Gratama, Gerrit Stoter, Egbert Oosterwijk. J Clin Oncol 2006
599
4

Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells.
Hongwei Du, Koichi Hirabayashi, Sarah Ahn, Nancy Porterfield Kren, Stephanie Ann Montgomery, Xinhui Wang, Karthik Tiruthani, Bhalchandra Mirlekar, Daniel Michaud, Kevin Greene,[...]. Cancer Cell 2019
155
4

Chimeric antigen receptor T-cell therapies for lymphoma.
Jennifer N Brudno, James N Kochenderfer. Nat Rev Clin Oncol 2018
268
4

Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome.
Yuying Liu, Yiliang Fang, Xinfeng Chen, Zhenfeng Wang, Xiaoyu Liang, Tianzhen Zhang, Mengyu Liu, Nannan Zhou, Jiadi Lv, Ke Tang,[...]. Sci Immunol 2020
114
4

Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma.
Shruti Gupta, Harish Seethapathy, Ian A Strohbehn, Matthew J Frigault, Elizabeth K O'Donnell, Caron A Jacobson, Shveta S Motwani, Samir M Parikh, Gary C Curhan, Kerry L Reynolds,[...]. Am J Kidney Dis 2020
34
11

Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma.
Jeremy S Abramson, Brianne McGree, Sarah Noyes, Sean Plummer, Curtis Wong, Yi-Bin Chen, Edwin Palmer, Tina Albertson, Judith A Ferry, Isabel C Arrillaga-Romany. N Engl J Med 2017
103
4

Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.
Carlos A Ramos, Brandon Ballard, Huimin Zhang, Olga Dakhova, Adrian P Gee, Zhuyong Mei, Mrinalini Bilgi, Meng-Fen Wu, Hao Liu, Bambi Grilley,[...]. J Clin Invest 2017
197
4


Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia.
Noelle V Frey, Pamela A Shaw, Elizabeth O Hexner, Edward Pequignot, Saar Gill, Selina M Luger, James K Mangan, Alison W Loren, Alexander E Perl, Shannon L Maude,[...]. J Clin Oncol 2020
77
5

Cardiac Profile of Chimeric Antigen Receptor T Cell Therapy in Children: A Single-Institution Experience.
Danielle S Burstein, Shannon Maude, Stephen Grupp, Heather Griffis, Joseph Rossano, Kimberly Lin. Biol Blood Marrow Transplant 2018
58
6

Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia.
Shuangyou Liu, Biping Deng, Zhichao Yin, Jing Pan, Yuehui Lin, Zhuojun Ling, Tong Wu, Dong Chen, Alex H Chang, Zhiyong Gao,[...]. Blood Cancer J 2020
53
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.